Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study

  • Etude concernée: PREDICT.amm
  • Auteurs / Authors: Loubière S, Drezet A, Beau-Faller M, Moro-Sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A, Léna H, Merle P, Mazières J, Zalcman G, Lacave R, Antoine M, Morin F, Missy P, Barlesi F, Auquier P, Cadranel J; French Cooperative Thoracic Intergroup (IFCT)
  • Journal / Conference: European Respiratory Journal
  • Année / Year: 2018
  • PMID: 29545318
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/29545318
  • PDF: IFCT-PREDICT.amm.pdf